glp-1 and type 1 diabetes SGLT2i RA therapy in and reno-vascular outcomes: a real-world study | Diabetologia GLP-1 Medications for Type 1

Glucagon-like peptide-1 receptor agonists (GLP-1s) mimic a natural hormone, primarily used for type 2 diabetes by regulating blood sugar and appetite and are increasingly used for weight loss by slowing gastric emptying and increasing fullness (Catanese, 2024)

More active individuals look into peptides for recovery to support ongoing training

With spending projections expecting continued sharp increases, PBMs have an important role to play in shaping prescription patterns more aligned with medical evidence (including trial data, treatment guidelines, medical best practices, etc.) and comparative research rather than drug maker promotional agendas

A convenient alternative to high-dose pills

Simultaneously, the liver itself becomes a target organ for injury in sepsis

Address recovery debt